16 results on '"Bassel H. Mahmoud"'
Search Results
2. 28694 Survey of patients’ wound care habits following Mohs micrographic surgery
- Author
-
Bassel H. Mahmoud, Vijaya T. Daniel, and Ailish M. Hanly
- Subjects
medicine.medical_specialty ,Wound care ,business.industry ,General surgery ,medicine ,Dermatology ,business ,Micrographic surgery - Published
- 2021
- Full Text
- View/download PDF
3. 26786 Delphi method study in defining surgical site infection following Mohs surgery
- Author
-
Bassel H. Mahmoud, Ailish M. Hanley, and Vijaya T. Daniel
- Subjects
medicine.medical_specialty ,business.industry ,General surgery ,medicine.medical_treatment ,Delphi method ,Mohs surgery ,Medicine ,Dermatology ,business ,Surgical site infection - Published
- 2021
- Full Text
- View/download PDF
4. Overview of Mohs micrographic surgery for the treatment of skin cancers
- Author
-
Bassel H. Mahmoud
- Subjects
030207 dermatology & venereal diseases ,03 medical and health sciences ,medicine.medical_specialty ,0302 clinical medicine ,business.industry ,030220 oncology & carcinogenesis ,medicine ,Dermatology ,business ,Micrographic surgery - Published
- 2016
- Full Text
- View/download PDF
5. Prospective Randomized Split-Face Comparative Study Between Topical Botulinum Toxin A Surface Application and Local Injection for Crow's Feet
- Author
-
David M. Ozog, Bassel H. Mahmoud, Christopher T. Burnett, and Joel L Cohen
- Subjects
medicine.medical_specialty ,business.industry ,Dermatology ,General Medicine ,030230 surgery ,Surgery ,Botulinum toxin a ,030207 dermatology & venereal diseases ,03 medical and health sciences ,Crow's feet ,0302 clinical medicine ,medicine ,Local injection ,business - Published
- 2016
- Full Text
- View/download PDF
6. Evaluation of Orbicularis Oculi Muscle Stripping on the Cosmetic Outcome of Upper Lid Blepharoplasty: A Randomized, Controlled Study
- Author
-
David J. Kouba, Austin Liu, Robert J. Sage, Matteo C. LoPiccolo, and Bassel H. Mahmoud
- Subjects
Blepharoplasty ,Male ,Cosmetic appearance ,medicine.medical_specialty ,medicine.medical_treatment ,Treatment outcome ,Dermatology ,law.invention ,Randomized controlled trial ,law ,medicine ,Humans ,Single-Blind Method ,Prospective Studies ,Prospective cohort study ,Surgical treatment ,Aged ,Orbicularis oculi muscle ,business.industry ,General Medicine ,Middle Aged ,Surgery ,Treatment Outcome ,medicine.anatomical_structure ,Oculomotor Muscles ,Female ,sense organs ,Eyelid ,business - Abstract
Background Many variations in the surgical treatment of upper eyelid blepharoplasty have been described, including orbicularis oculi muscle stripping. There is no evidence in the literature to support the efficacy of this technique in improving the aesthetic results of the procedure. Objectives To conduct a single-blind, randomized, controlled, split-face pilot study to evaluate the effects of orbicularis oculi muscle stripping on upper lid blepharoplasty. Methods Ten subjects were randomized to receive upper lid blepharoplasty with orbicularis oculi muscle stripping on one side and skin-only blepharoplasty on the other. Patients and two blinded physicians evaluated the aesthetics of the eyelids at 1-, 3-, and 17-month follow-up visits. Results Blinded physician evaluation failed to show a difference in the overall cosmetic appearance of the eyelids between the control and treatment sides at any time point. Analysis of the composite of all patient scores showed a trend favoring the control side at 3 months (p = .28) and the treatment side at 17 months (p = .50), but neither difference was significant. Conclusion Based on the data from this pilot study, orbicularis oculi muscle stripping appears to have no affect on the aesthetic outcome of upper lid blepharoplasty.
- Published
- 2013
- Full Text
- View/download PDF
7. Systemic analyses of immunophenotypes of peripheral T cells in non-segmental vitiligo: implication of defective natural killer T cells
- Author
-
Iltefat H. Hamzavi, Marsha Henderson, Tian Wen Gao, Xiaofan Mi, Henry W. Lim, Kai Li, Oma N. Agbai, Richard H. Huggins, Yuling Shi, Bassel H. Mahmoud, Qing-Sheng Mi, and Li Zhou
- Subjects
medicine.medical_treatment ,FOXP3 ,hemic and immune systems ,chemical and pharmacologic phenomena ,Dermatology ,Vitiligo ,Biology ,Natural killer T cell ,medicine.disease ,General Biochemistry, Genetics and Molecular Biology ,Immune tolerance ,Cytokine ,Immunophenotyping ,Oncology ,Immunology ,medicine ,IL-2 receptor ,CD8 - Abstract
Although it is widely believed that non-segmental vitiligo (NSV) results from the autoimmune destruction of melanocytes, a clear understanding of defects in immune tolerance, which mediate this uncontrolled self-reactivity, is still lacking. In the present study, we systemically evaluated circulating regulatory T (Treg) cells, including CD4(+) CD25(+) FoxP3(+) Treg cells and invariant natural killer T (iNKT) cells, as well as naive and memory CD4(+) and CD8(+) T cells and their cytokine production, in a cohort of 43 progressive NSV patients with race-, gender-, and age-matched healthy controls. We found that the general immunophenotypes of CD4(+) and CD8(+) T cells and the percentage of CD4(+) CD25(+) FoxP3(+) Tregs were comparable between NSV and healthy controls. However, percentages of peripheral iNKT cells were significantly decreased in NSV patients compared to that in healthy controls. Our data confirm the previous notion that the percentage of peripheral CD4(+) CD25(+) FoxP3(+) Tregs remains unaltered in NSV and suggests the involvement of defective iNKT cells in the pathogenesis of NSV.
- Published
- 2012
- Full Text
- View/download PDF
8. Optimizing Closure Materials for Upper Lid Blepharoplasty: A Randomized, Controlled Trial
- Author
-
David J. Kouba, Denise Woo, Bassel H. Mahmoud, and Emily P. Tierney
- Subjects
Blepharoplasty ,Male ,medicine.medical_specialty ,Esthetics ,medicine.medical_treatment ,Scars ,Dermatology ,Statistics, Nonparametric ,law.invention ,Postoperative Complications ,Randomized controlled trial ,Suture (anatomy) ,law ,Surgical Wound Dehiscence ,medicine ,Humans ,Prospective Studies ,Prospective cohort study ,business.industry ,Suture Techniques ,digestive, oral, and skin physiology ,Cosmesis ,General Medicine ,Middle Aged ,Surgery ,Treatment Outcome ,medicine.anatomical_structure ,Female ,Tissue Adhesives ,Eyelid ,medicine.symptom ,business - Abstract
BACKGROUND Although upper eyelid blepharoplasty is a common procedure, subtleties in surgical technique can affect cosmetic outcomes. Suture materials commonly used include polypropylene, monofilament nylon, fast-absorbing gut, and ethylcyanoacrylate (ECA) tissue adhesive. OBJECTIVE To assess upper lid blepharoplasty scars in participants whose incision had been closed with 6-0 polypropylene sutures, 6-0 fast-absorbing gut sutures, or ECA. MATERIALS AND METHODS A randomized, split-eyelid, single-blind, prospective study of the short- (1 month) and intermediate-term (3 months) efficacy of polypropylene, fast-absorbing gut, and ECA on 36 consecutive upper lid blepharoplasties. Participants and a blinded physician evaluator evaluated cosmetic outcome 1 and 3 months after the procedure. RESULTS Three subgroups tested were ECA versus fast-absorbing gut, ECA versus polypropylene, and fast-absorbing gut versus polypropylene. At 1 month, ECA was superior to fast-absorbing gut (p=.03) and had a marginally better outcome than polypropylene (p=.25), and polypropylene had an equivalent outcome to fast-absorbing gut (p=.46). At 3-month follow-up, ECA remained superior to fast-absorbing gut (p=.03). CONCLUSION Although sutured epidermal closure and tissue adhesive are highly efficacious for upper eyelid blepharoplasty, physicians and participants felt that cosmesis with ECA was superior to that with fast-absorbing gut.
- Published
- 2011
- Full Text
- View/download PDF
9. 1292 Comparative study of the immunological profile in stable segmental and non segmental vitiligo patients undergoing melanocyte keratinocyte transplantation
- Author
-
John E. Harris, D. Goldberg, Michael L. Frisoli, Essam A. Nada, James P. Strassner, Bassel H. Mahmoud, Mohammed Ali, Maggi Ahmed Refat, M. Rashighi, and Ramadan A Saleh
- Subjects
Pathology ,medicine.medical_specialty ,business.industry ,Segmental vitiligo ,Cell Biology ,Dermatology ,Melanocyte ,Biochemistry ,Transplantation ,medicine.anatomical_structure ,medicine ,business ,Keratinocyte ,Molecular Biology - Published
- 2018
- Full Text
- View/download PDF
10. Safety and Efficacy of Erbium-Doped Yttrium Aluminum Garnet Fractionated Laser for Treatment of Acne Scars in Type IV to VI Skin
- Author
-
Henry W. Lim, James J. Yang, Divya Srivastava, David M. Ozog, Bassel H. Mahmoud, and Jennifer J. Janiga
- Subjects
Male ,medicine.medical_specialty ,Skin Pigmentation ,Lasers, Solid-State ,Dermatology ,law.invention ,Cicatrix ,Randomized controlled trial ,law ,Surveys and Questionnaires ,Acne Vulgaris ,Ablative case ,Humans ,Medicine ,Single-Blind Method ,In patient ,Prospective Studies ,Low-Level Light Therapy ,Acne scars ,business.industry ,Fitzpatrick Skin Type I ,Significant difference ,General Medicine ,Laser ,Surgery ,Treatment Outcome ,Patient Satisfaction ,Face ,Female ,medicine.symptom ,business ,Postinflammatory hyperpigmentation ,Follow-Up Studies - Abstract
BACKGROUND Ablative resurfacing lasers are effective for treatment of acne scars, but they have a high risk of complications. Fractional lasers have less severe side effects but more moderate efficacy than ablative devices. Studies were performed in individuals with Fitzpatrick skin type I to VI. OBJECTIVE To determine the efficacy and safety of an erbium 1,550-nm fractional laser in the treatment of facial acne scars in Fitzpatrick skin types IV to VI. METHODS We conducted a prospective, single-blind, randomized trial in patients with acne scars (n=15), skin type IV to VI, with a 1,550-nm erbium fractionated laser. Patients were divided into two groups; one was treated with 10 mJ and the other with 40 mJ. Five monthly laser sessions were performed. A patient questionnaire was distributed. RESULTS There was a significant improvement in the acne scarring and overall appearance (p
- Published
- 2010
- Full Text
- View/download PDF
11. Prospective controlled clinical and histopathologic study of hidradenitis suppurativa treated with the long-pulsed neodymium:yttrium-aluminium-garnet laser
- Author
-
John C. Pui, Emily P. Tierney, Camile L. Hexsel, Bassel H. Mahmoud, Iltefat H. Hamzavi, and David M. Ozog
- Subjects
Adult ,Male ,medicine.medical_specialty ,Lasers, Solid-State ,Dermatology ,Intertriginous ,Benzoyl peroxide ,law.invention ,Young Adult ,Patient satisfaction ,Randomized controlled trial ,law ,medicine ,Humans ,Hidradenitis suppurativa ,Prospective Studies ,Aged ,business.industry ,Clindamycin ,Anatomical pathology ,Middle Aged ,medicine.disease ,Hidradenitis Suppurativa ,Surgery ,Female ,Histopathology ,business ,medicine.drug - Abstract
Hidradenitis suppurativa (HS) is a chronic inflammatory disease involving the intertriginous areas.We sought to conduct clinical and histopathologic evaluation of the efficacy of long-pulsed neodymium:yttrium-aluminium-garnet laser treatment for HS.We conducted a prospective, randomized, right-left within-patient controlled trial for HS (n = 22). Four monthly laser sessions were performed. Disease activity was measured at baseline, and treatment response was assessed before each laser session and monthly for 2 months after the completion of laser treatment, using a modified scoring system based on Sartorius score. Histologic examination was performed at baseline, immediately after laser treatment, and at 1 and 4 weeks after treatment. A patient questionnaire was circulated on the last visit to assess patients' level of satisfaction.There was progressive improvement in disease activity, most significantly during the 4 months of treatment, which was maintained during the 2-month posttreatment follow-up period. Averaged over all anatomic sites, the percent improvement was 72.7% on the laser treated side, and 22.9% on the control side (P.05). Histologic examination showed an initial acute neutrophilic infiltrate. Granulomatous inflammation was present on follow-up biopsy specimens 4 weeks later. An inflammatory infiltrate surrounded the hair shaft remnants, denoting destruction of hair follicles.Small sample size was a limitation.Long-pulsed neodymium:yttrium-aluminium-garnet laser, together with topical benzoyl peroxide and clindamycin, is significantly more effective than topical benzoyl peroxide and clindamycin alone for the treatment of HS. Preliminary review of histopathology suggests the mechanism of action is destruction of the hair follicle. The overall success of the treatment in both clearing pre-existing lesions and preventing new eruptions, coupled with high patient satisfaction, makes the neodymium:yttrium-aluminium-garnet laser a promising treatment advance for this highly disabling condition.
- Published
- 2010
- Full Text
- View/download PDF
12. Randomized Control Trial for the Treatment of Hidradenitis Suppurativa with a Neodymium-Doped Yttrium Aluminium Garnet Laser
- Author
-
Bassel H. Mahmoud, Emily P. Tierney, Camile L. Hexsel, Iltefat H. Hamzavi, and David M. Ozog
- Subjects
Adult ,Male ,medicine.medical_specialty ,chemistry.chemical_element ,Lasers, Solid-State ,Dermatology ,Neodymium ,law.invention ,chemistry.chemical_compound ,Randomized controlled trial ,law ,Aluminium ,Yttrium aluminium garnet ,medicine ,Humans ,Effective treatment ,Hidradenitis suppurativa ,Prospective Studies ,business.industry ,General Medicine ,Yttrium ,medicine.disease ,Laser ,Hidradenitis Suppurativa ,chemistry ,Female ,Surgery ,Laser Therapy ,business - Abstract
Hidradenitis suppurativa (HS) is a chronic suppurative condition for which there is limited efficacy of medical and surgical treatments.To assess whether the 1,064-nm neodymium-doped yttrium aluminium garnet (Nd:YAG) laser is an effective treatment for HS.Prospective, randomized, controlled study for patients with stage II to III HS disease (n=22). A series of 3 monthly laser sessions were performed. Treatment response was measured before each laser session and 1 month after the completion of laser treatment (HS Lesion, Area, and Severity Index (HS-LASI) scale). A modification was made to include symptoms (erythema, edema, pain, and purulent discharge; modified HS-LASI, 0-3 scale).The percentage change in HS severity after 3 months of treatment was -65.3% over all anatomic sites, -73.4% inguinal, -62.0% axillary, and -53.1% inframammary. For all anatomic sites combined and each individual anatomic site, the change in HS severity from baseline to month 3 was statistically significant at the treated sites (p.02 for modified HS-LASI and HS-LASI) but not at the control sites (p.05 for modified HS-LASI and HS-LASI).The long-pulse Nd:YAG laser is effective for treatment of HS. The effectiveness of Nd:YAG laser, a hair epilation device, supports the primary follicular pathogenesis of the condition.
- Published
- 2009
- Full Text
- View/download PDF
13. A clinical trial and molecular study of photoadaptation in vitiligo
- Author
-
C. L. Hexsel, Iltefat H. Hamzavi, Faith M. Strickland, J. Rivard, Henry W. Lim, Bassel H. Mahmoud, M. Owen, and David Mitchell
- Subjects
Adult ,Male ,medicine.medical_specialty ,DNA Repair ,Vitiligo ,Skin Pigmentation ,Dermatology ,Radiation Tolerance ,Minimal erythema dose ,medicine ,Humans ,Pigmentation disorder ,Aged ,Skin ,Single exposure ,integumentary system ,business.industry ,Radiotherapy Dosage ,Ultraviolet b ,Middle Aged ,medicine.disease ,Adaptation, Physiological ,Clinical trial ,Female ,Ultraviolet Therapy ,Pigmented skin ,Normal skin ,business ,DNA Damage - Abstract
Summary Background Photoadaptation to ultraviolet (UV) B phototherapy is due to both pigmentary and nonpigmentary influences. Objectives To measure photoadaptation in vitiliginous skin and to compare it with normal pigmented skin. Methods Seventeen patients with Fitzpatrick skin phototypes III–VI with vitiligo received six to nine UVB treatments, two to three times weekly. Minimal erythema dose (MED) testing was done at baseline and after all treatments; the percentage change in MED was analysed as a measure of photoadaptation. The percentage decrease in cyclobutane pyrimidine dimers (CPDs) over 24 h after a single exposure of 1 MED was analysed on vitiliginous and normal skin. Results The mean ± SD percentage change in MED from before to after treatments was: treated vitiliginous skin 28·5 ± 39·9% (P = 0·015), treated normal skin 35·9 ± 49·9% (P = 0·015), untreated vitiliginous skin 11·9 ± 22·6% (P =0·070), untreated normal skin 25·1 ± 41·3% (P = 0·041). Of these patients, two-thirds had a positive percentage change in MED (photoadaptation). The mean amount of CPDs induced per megabase of DNA immediately after exposure was significantly higher in vitiliginous skin. The mean ± SD percentage decrease in CPDs (rate of repair) in 24 h was 35·7 ± 26·8% in vitiliginous skin (P = 0·027) and 46·2 ± 19·5% in normally pigmented skin (P = 0·001); no difference was noted in the repair in vitiliginous skin compared with normal skin (P = 0·4). Conclusions Photoadaptation in vitiliginous and normal skin was observed in two-thirds of patients. Vitiliginous skin had significantly more CPDs following UVB exposure; the rate of repair of UVB-induced DNA damage was equivalent to that in normal skin.
- Published
- 2009
- Full Text
- View/download PDF
14. Effects of Visible Light on the Skin
- Author
-
Henry W. Lim, Bassel H. Mahmoud, Camile L. Hexsel, and Iltefat H. Hamzavi
- Subjects
Sunlight ,Light ,integumentary system ,business.industry ,Chemistry ,Infrared ,medicine.medical_treatment ,Human skin ,General Medicine ,Intense pulsed light ,Biochemistry ,Indirect DNA damage ,Electromagnetic radiation ,Electromagnetic Fields ,medicine ,Humans ,Optoelectronics ,Physical and Theoretical Chemistry ,business ,Skin ,Action spectrum ,Visible spectrum - Abstract
Electromagnetic radiation has vast and diverse effects on human skin. Although photobiologic studies of sunlight date back to Sir Isaac Newton in 1671, most available studies focus on the UV radiation part of the spectrum. The effects of visible light and infrared radiation have not been, until recently, clearly elucidated. The goal of this review is to highlight the effects of visible light on the skin. As a result of advances in the understanding of skin optics, and comprehensive studies regarding the absorption spectrum of endogenous and exogenous skin chromophores, various biologic effects have been shown to be exerted by visible light radiation including erythema, pigmentation, thermal damage and free radical production. It has also been shown that visible light can induce indirect DNA damage through the generation of reactive oxygen species. Furthermore, a number of photodermatoses have an action spectrum in the visible light range, even though most of the currently available sunscreens offer, if any, weak protection against visible light. Conversely, because of its cutaneous biologic effects, visible light is used for the treatment of a variety of skin diseases and esthetic conditions in the form of lasers, intense pulsed light and photodynamic therapy.
- Published
- 2008
- Full Text
- View/download PDF
15. Quantitative skin color measurements in acanthosis nigricans patients: colorimetry and diffuse reflectance spectroscopy
- Author
-
Bensachee, Pattamadilok, Suneetha, Devpura, Zain U, Syed, Oma N, Agbai, Pranita, Vemulapalli, Marsha, Henderson, Steven J, Rehse, Bassel H, Mahmoud, Henry W, Lim, Ratna, Naik, and Iltefat H, Hamzavi
- Subjects
Melanins ,Hemoglobins ,Adolescent ,Oxyhemoglobins ,Spectrum Analysis ,Humans ,Colorimetry ,Female ,Skin Pigmentation ,Acanthosis Nigricans ,Child ,Skin - Abstract
Tristimulus colorimetry and diffuse reflectance spectroscopy (DRS) are white-light skin reflectance techniques used to measure the intensity of skin pigmentation. The tristimulus colorimeter is an instrument that measures a perceived color and the DRS instrument measures biological chromophores of the skin, including oxy- and deoxyhemoglobin, melanin and scattering. Data gathered from these tools can be used to understand morphological changes induced in skin chromophores due to conditions of the skin or their treatments. The purpose of this study was to evaluate the use of these two instruments in color measurements of acanthosis nigricans (AN) lesions. Eight patients with hyperinsulinemia and clinically diagnosable AN were seen monthly. Skin pigmentation was measured at three sites: the inner forearm, the medial aspect of the posterior neck, and anterior neck unaffected by AN. Of the three, measured tristimulus L*a*b* color parameters, the luminosity parameter L* was found to most reliably distinguish lesion from normally pigmented skin. The DRS instrument was able to characterize a lesion on the basis of the calculated melanin concentration, though melanin is a weak indicator of skin change and not a reliable measure to be used independently. Calculated oxyhemoglobin and deoxyhemoglobin concentrations were not found to be reliable indicators of AN. Tristimulus colorimetry may provide reliable methods for respectively quantifying and characterizing the objective color change in AN, while DRS may be useful in characterizing changes in skin melanin content associated with this skin condition.
- Published
- 2012
16. Granuloma annulare treated with rifampin, ofloxacin, and minocycline combination therapy
- Author
-
Dione V. Marcus, Iltefat H. Hamzavi, and Bassel H. Mahmoud
- Subjects
Adult ,Male ,Pathology ,medicine.medical_specialty ,Ofloxacin ,Combination therapy ,Minocycline ,Dermatology ,Granuloma Annulare ,Pharmacotherapy ,Medicine ,Humans ,Granuloma annulare ,Antibacterial agent ,Aged ,Aged, 80 and over ,business.industry ,Papule ,General Medicine ,Middle Aged ,medicine.disease ,Anti-Bacterial Agents ,Drug Therapy, Combination ,Female ,medicine.symptom ,Rifampin ,business ,Rifampicin ,Postinflammatory hyperpigmentation ,medicine.drug - Abstract
Granuloma annulare (GA) is a benign, usually self-limiting, dermatosis, that typically presents as asymptomatic, flesh-colored or erythematous papules, frequently arranged in an annular or arciform pattern on the distal extremities. Although localized GA is most commonly observed, a generalized or disseminated form can occur. The etiology of GA is unknown; however, multiple inciting factors have been proposed. Histologically, GA is characterized by foci of degenerative collagen associated with palisading, sometimes infiltrating granulomatous inflammation.We report 6 cases with biopsy-proved GA, resistant to the standard modalities of treatment that resolved after 3 months with monthly rifampin (600 mg), ofloxacin (400 mg), and minocycline hydrochloride (100 mg) combination therapy. Rifampin, ofloxacin, and minocycline combination therapy has been successfully used to treat patients with paucibacillary leprosy. Given reports that prolonged antibiotic agents are a useful treatment for GA, rifampin (600 mg), ofloxacin (400 mg), and minocycline hydrochloride (100 mg) combination therapy was initiated in these patients. Complete clearance of the plaques was achieved 3 to 5 months after the initiation of treatment. Some patients experienced postinflammatory hyperpigmentation.Although our treatment was effective, further studies may be needed to confirm the success of this therapeutic option for patients with recalcitrant lesions of GA.
- Published
- 2009
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.